EPISODE CLINIC
Ko
KoKoChChEnEnJaJaTwTwArArThTh

# Mounjaro EPISODE

Mounjaro is a prescription drug containing tirzepatide, a GIP/GLP-1 receptor dual-acting injectable, approved as an adjunct to diet and exercise therapy. It is administered once a week via subcutaneous injection, and side effects such as nausea, vomiting, and diarrhea may occur. At EPISODE CLINIC, the decision to prescribe the medication is made after a visit and consultation with a doctor.

Body Contour Detail

Tune Body PrimeBody Ultherapy PRIMEBody Shurink UniverseFace Diamond CutFace FitBody Diamond CutBody FitVioletMounjaro
Mounjaro Introduction Banner, Primary Function: Weight Management PrescriptionMounjaro treatment Information Panel: Weight management prescription guide, Tircepatide GIP/GLP-1 receptor dual-acting injectable, treatment interval 1 week, treatment time within 10 minutes, no anesthesia, daily activities possible on the same dayProduct photo of Mounjaro and three domestically approved indications (obese adult patients, overweight patients with obesity-related comorbidities, and adult patients with obstructive sleep apnea), diagram of the mechanism of action, and prescription drug information.Mounjaro Pre-filled Pen Structure, Injection Sites (Abdomen, Thigh, Back of Upper Arm), 3-Step Administration GuideMounjaro Q&A: Timing of administration, handling of missed dates (within 4 days), storage (refrigerated at 2–8°C, maximum 21 days at room temperature), side effects (nausea, vomiting, diarrhea), references

Events / Price Guide